Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma.
Steendam CMJ, Peric R, van Walree NC, Youssef M, Schramel FMNH, Brocken P, van Putten JWG, van der Noort V, Veerman GDM, Koolen SLW, Groen HJM, Dingemans AC, Mathijssen RHJ, Smit EF, Aerts JGJV; NVALT Study Group.
Steendam CMJ, et al. Among authors: van putten jwg.
Lung Cancer. 2021 Oct;160:44-49. doi: 10.1016/j.lungcan.2021.08.002. Epub 2021 Aug 4.
Lung Cancer. 2021.
PMID: 34403911
Free article.
Clinical Trial.